Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 9/20 | 0.64 |
| ▸ | EGFR | P00533 | 8/20 | 0.58 |
| ▸ | SRC | P12931 | 5/20 | 0.58 |
| ▸ | KDR | P35968 | 1/20 | 0.58 |
| ▸ | ERBB2 | P04626 | 7/20 | 0.58 |
| ▸ | RAF1 | P04049 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4455183 | 0.91 | EGFR (0.69) | MAP2K1EGFRSRCERBB2 | |
| SCHEMBL4448819 | 0.86 | EGFR (0.62) | MAP2K1EGFRSRCERBB2 | |
| SCHEMBL4450574 | 0.86 | MAP2K1 (0.58) | MAP2K1EGFRSRCERBB2 | |
| SCHEMBL6998602 | 0.85 | MAP2K1 (0.62) | MAP2K1EGFRSRCERBB2RAF1 | |
| SCHEMBL18620468 | 0.81 | MAP2K1 (0.80) | MAP2K1EGFRSRCERBB2RAF1 | |
| SCHEMBL4954951 | 0.80 | MAP2K1 (0.76) | MAP2K1EGFRSRCKDRERBB2 | |
| SCHEMBL2063734 | 0.78 | MAP2K1 (0.68) | MAP2K1EGFRSRCKDRERBB2 | |
| SCHEMBL28756490 | 0.77 | MAP2K1 (0.95) | MAP2K1EGFRSRCERBB2RAF1 | |
| SCHEMBL6989870 | 0.77 | EGFR (0.49) | MAP2K1EGFRSRCERBB2 | |
| SCHEMBL6183876 | 0.76 | SRC (0.78) | MAP2K1EGFRSRCERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1117659-B1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | WYETH CORP (US) | 2003-12-03 | — | — | EP | disclosed |
| US-6288082-B1 | COMPOUNDS SUCH AS 6,7-DIETHOXY-4-(INDAN-5-YLAMINO) -QUINOLINE-3-CARBONITRILE USED AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYCSTIC KIDNEY DISEASE | AMERICAN CYANAMID COMPANY | 2001-09-11 | — | — | US | disclosed |
| EP-1117659-A1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | American Cyanamid Company (US) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000018761-A1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-04-06 | — | — | WO | disclosed |